Skip to main content
Addgene

IRES-puro-GFP
(Plasmid #16616)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 16616 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pIRESpuro2
  • Backbone manufacturer
    Clontech
  • Backbone size w/o insert (bp) 5200
  • Vector type
    Mammalian Expression
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    GFP
  • Alt name
    Green fluorescent protein
  • Insert Size (bp)
    700

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NheI (not destroyed)
  • 3′ cloning site EcoRI (not destroyed)
  • 5′ sequencing primer CMV-F
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

This is an improved version of the vector used in the publication.

Note that although the SnapGene software recognizes the fluorescent protein as EYFP, this variant does not have the mutations required to convert GFP to YFP, and so should function more similarly to GFP.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    IRES-puro-GFP was a gift from Bert Vogelstein (Addgene plasmid # 16616 ; http://n2t.net/addgene:16616 ; RRID:Addgene_16616)
  • For your References section:

    Use of isogenic human cancer cells for high-throughput screening and drug discovery. Torrance CJ, Agrawal V, Vogelstein B, Kinzler KW. Nat Biotechnol. 2001 Oct . 19(10):940-5. 10.1038/nbt1001-940 PubMed 11581659